[66Ga]Oxine complex preparation and stability as a possible PET radiopharmaceutical.

Authors

  • A. J. Novinrooz
  • A. R. Jalilian
  • A. Rahiminejad
  • A.A. Rajamand
  • P. Rowshanfarzad
Abstract:

Background: Gallium-66 (T1/2= 9.49 h) is an interesting radionuclide that has potential for positron emission tomography (PET) imaging of biological processes in intermediate to slow target tissue uptake. Oxine has been labeled with this radioisotope in the form of [66Ga]gallium chloride for its possible diagnostic properties. Materials and methods: 66Ga was produced in the 30 MeV cyclotron (Cyclon-30, IBA) via the 66Zn(p,n)66Ga reaction.TLC was performed on polymer backed silica gel. A Gamma spectrometer HPGe detector was used for countings. Results: After the bombardment, the production yield was 11.2 mCi/ m Ah. The [66Ga]Oxine complex was obtained at the pH=5 in phosphate buffer medium at 37 ° C in 10 minutes. Radio-TLC showed an overall radiochemical yield of 97% (radiochemical purity > 98%). The chemical stability of the complex was checked in vitro with a specific activity of 896 mCi/ml. Conclusion: [66Ga]oxine can be used in diagnostic studies due to its suitable physico-chemical properties both in vitro and in vivo. Iran . J. Radiat. Res., 2003 1(3): 157 - 161

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

[66ga]oxine complex preparation and stability as a possible pet radiopharmaceutical.

background: gallium-66 (t1/2= 9.49 h) is an interesting radionuclide that has potential for positron emission tomography (pet) imaging of biological processes in intermediate to slow target tissue uptake. oxine has been labeled with this radioisotope in the form of [66ga]gallium chloride for its possible diagnostic properties. materials and methods: 66ga was produced in the 30 mev cyclotron (cy...

full text

Preparation of [64Cu] Pyruvaldehyde-bis (N4-methylthiosemicarbazone) complex as a PET and/or therapeutic radiopharmaceutical

Background: Copper-64 (T1/2=12.7 h) is an important radionuclide used both in PET imaging and therapy. [64Cu]-pyruvaldehyde-bis (N4-methylthiosemicarbazone) ([64Cu]-PTSM) is one of the most famous copper radiopharmaceuticals with unique specifications (suitable half life, stability, etc.). The wide range of 64Cu applications arouse great interest for its production. Materials and Methods: Cu-64...

full text

preparation of [64cu] pyruvaldehyde-bis (n4-methylthiosemicarbazone) complex as a pet and/or therapeutic radiopharmaceutical

background: copper-64 (t1/2=12.7 h) is an important radionuclide used both in pet imaging and therapy. [64cu]-pyruvaldehyde-bis (n4-methylthiosemicarbazone) ([64cu]-ptsm) is one of the most famous copper radiopharmaceuticals with unique specifications (suitable half life, stability, etc.). the wide range of 64cu applications arouse great interest for its production. materials and methods: cu-64...

full text

Preparation of a 153Sm-5,10,15,20-tetrakis(4-methoxyphenyl) porphyrin complex as a possible therapeutic agent

Introduction: Porphyrins are interesting derivatives with low toxicity, tumor avidity and rapid wash-out suggested as potential radiopharmaceuticals in radiolabeled form. In this work we report, synthesis, radiolabeling, quality control, stability, partition coefficient determination and biodistribution studies of 153Sm-5,10,15,20-tetrakis(4-methoxyphenyl) porphyrin (153Sm-4-MPP) in ...

full text

Synthesis and Preclinical Studies of [61Cu]-N-(2-Hydroxyacetophenone)glycinate as a Possible PET Radiopharmaceutical

Cu]-N-(2-hydroxyacetophenone)glycinate ([Cu]NHAG) was prepared using in house-made NHAG ligand and [Cu]CuCl2 produced via the Zn(p,x)Cu (180μA proton irradiation, 22MeV, 3.2h) and purified by a ion chromatography method. [Cu]NHAG radiochemical purity was >98% and >99.9% by RTLC and HPLC methods respectively after purification by SPE. [Cu]NHAG was administered into normal and tumor bearing mice ...

full text

Development of 153Sm/177Lu-EDTMP as a possible therapeutic complex

Introduction:Targeted radionuclide therapy (TRT) has been demonstrated to be an effective therapeutic tool in patients with disseminated bone metastasis. TRT is generally performed with a single radionuclide. In this study we investigated the feasibility of combined TRT with a high-energy beta emitter (153Sm) and a low energy beta emitter (177Lu) in wistar...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 1  issue None

pages  157- 161

publication date 2003-12

By following a journal you will be notified via email when a new issue of this journal is published.

Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023